R&D Systems™ Recombinant Human BCAT2 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human BCAT2 Protein is derived from E. coli. The Recombinant Human BCAT2 Protein has been validated for the following applications: Enzyme Activity.

Specifications

• Accession Number: O15382-1
• Characterization: Enzyme Activity
• For Use With (Application): Enzyme Activity
• Formulation: Supplied as a 0.2μm filtered solution in Tris, NaCl, DTT and Glycerol.
• Gene ID (Entrez): 587
• Molecular Weight (g/mol): 42kDa
• Quantity: 20 μg
• Source: E. coli-derived human BCAT2 protein Ala28-Val392 with an N-terminal Met and 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
• Endotoxin Concentration: <0.10EU per 1μg of the protein by the LAL method.
• Gene Alias: BCAM, BCAT(m), BCATM, BCT2, BCT2EC 2.6.1.42, branched chain amino-acid transaminase 2, mitochondrial, branched chain aminotransferase 2, mitochondrial, branched-chain-amino-acid aminotransferase, mitochondrial, Eca40, Placental protein 18, PP18
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.